HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Goldman Sachs Gains 2 Board Seats With Burst Subscription Oral Care Investment

Executive Summary

Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.

You may also be interested in...



NanoBio Nasal Antiseptic, Burst Oral-Care Probiotics And More: Personal Care Launch News

Recent personal-care product launches show companies innovating in emerging frontiers and hazily regulated territory with probiotic oral care, over-the-counter fungal nail care and nasal antiseptic care. Elsewhere, sensitive skin specialist Cetaphil introduces ultra-moisturizing products, and Nestle Health Sciences’ Atrium Innovations launches a line of nutritional supplements for skin, hair and nail health.

Subscription Oral Care Marketer Burst Adjusts Brand Building Program To COVID-19 Shutdowns

The firm says during COVID-19 pandemic, it is waiving the $20 registration fee for its Burst Ambassador program to assist dental hygienists whose offices have closed temporarily, or remain open but put them at risk through close contact with patients and co-workers, potential contamination of saliva and shortage of protective equipment.

US Consumer Health Recalls: Still Another Glitch For OTC Hand Sanitizers, ED-Spiked Supplements

Kimberly-Clark's recall of nearly 3,000 cases of Foam Skin Cleanser soap incorrectly labeled as Moisturizing Foam Hand Sanitizer is among recent recalls added to FDA records.

Topics

UsernamePublicRestriction

Register

RS150075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel